NCT06904638 Underprescribing in Geriatric Patients: a Prevalence Study and Analysis of Factors Contributing to Potential Prescription Omissions (Under-PRES)
| NCT ID | NCT06904638 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istituto Nazionale di Ricovero e Cura per Anziani |
| Condition | Older People |
| Study Type | OBSERVATIONAL |
| Enrollment | 374 participants |
| Start Date | 2024-06-20 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 374 participants in total. It began in 2024-06-20 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study will determine the prevalence of underprescription in a cohort of elderly patients, recruited at the time of an outpatient geriatric visit, or hospitalized, upon admission to a geriatric ward.
Eligibility Criteria
Inclusion Criteria: * Geriatric ward admission or outpatient geriatric appointment * Capacity to provide informed consent by the patient or legal guardian Exclusion Criteria: * Limited life expectancy as measured by the Clinical Frailty Scale (CFS) \>8
Contact & Investigator
Antonio Cherubini, MD
STUDY CHAIR
IRCCS INRCA, Ancona, Italy
Frequently Asked Questions
Who can join the NCT06904638 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Older People. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06904638 currently recruiting?
Yes, NCT06904638 is actively recruiting participants. Contact the research team at a.bonfigli@inrca.it for enrollment information.
Where is the NCT06904638 trial being conducted?
This trial is being conducted at Ancona, Italy, Cosenza, Italy.
Who is sponsoring the NCT06904638 clinical trial?
NCT06904638 is sponsored by Istituto Nazionale di Ricovero e Cura per Anziani. The principal investigator is Antonio Cherubini, MD at IRCCS INRCA, Ancona, Italy. The trial plans to enroll 374 participants.